{
    "Trade/Device Name(s)": [
        "EliA dsDNA Immunoassay",
        "EliA ANA Control"
    ],
    "Submitter Information": "Phadia AB",
    "510(k) Number": "K072393",
    "Predicate Device Reference 510(k) Number(s)": [
        "K874873"
    ],
    "Regulatory Class": "Class II, Class I",
    "Product Code(s)": [
        "LRM",
        "JJY",
        "LSW"
    ],
    "Summary Letter Date": "December 7, 2007",
    "Summary Letter Received Date": "November 27, 2007",
    "Submission Date": "November 26, 2007",
    "Regulation Number(s)": [
        "21 CFR 866.5100",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Antinuclear autoantibody, antigen and control"
    ],
    "Analyte Class(es)": [
        "immunology",
        "autoimmune"
    ],
    "Analyte(s)": [
        "IgG antibodies to dsDNA",
        "Antinuclear antibodies (ANA)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Heparin tube",
        "EDTA tube",
        "Citrate tube"
    ],
    "Instrument(s)/Platform(s)": [
        "ImmunoCAP 100",
        "ImmunoCAP 250"
    ],
    "Method(s)/Technology(ies)": [
        "Fluorescence Immunoassay"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Control",
        "Reagent",
        "Calibrator"
    ],
    "Document Summary": "FDA 510(k) summary for EliA dsDNA Immunoassay and ANA Control for quantitative measurement of IgG antibodies to dsDNA and monitoring ANA performance using automated immunoassay analyzers.",
    "Indications for Use Summary": "Aids in the in vitro quantitative measurement of IgG antibodies to dsDNA for diagnosing systemic lupus erythematosus (SLE), and in monitoring laboratory performance of ANA measurement, using ImmunoCAP 100 or 250 instruments.",
    "fda_folder": "Immunology"
}